Cao Y - Search Results

1

CDC5L drives FAH expression to promote metabolic reprogramming in melanoma.

Gu Z, Zhang H, Li Y, Shen S, Yin X, Zhang W, Cheng R, Zhang Y, Zhang X, Chen H, Huang B, Cao Y. Gu Z, et al. Among authors: cao y. Oncotarget. 2017 Dec 7;8(69):114328-114343. doi: 10.18632/oncotarget.23107. eCollection 2017 Dec 26. Oncotarget. 2017. PMID: 29371990 Free PMC article.

2

Local accumulation of FOXP3+ regulatory T cells: evidence for an immune evasion mechanism in patients with large condylomata acuminata.

Cao Y, Zhao J, Lei Z, Shen S, Liu C, Li D, Liu J, Shen GX, Zhang GM, Feng ZH, Huang B. Cao Y, et al. J Immunol. 2008 Jun 1;180(11):7681-6. doi: 10.4049/jimmunol.180.11.7681. J Immunol. 2008. PMID: 18490771

3

CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy.

Cao Y, Zhao J, Yang Z, Cai Z, Zhang B, Zhou Y, Shen GX, Chen X, Li S, Huang B. Cao Y, et al. Clin Immunol. 2010 Jul;136(1):21-9. doi: 10.1016/j.clim.2010.02.020. Epub 2010 Mar 24. Clin Immunol. 2010. PMID: 20338811 Clinical Trial.

4

Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels.

Zhao J, Cao Y, Lei Z, Yang Z, Zhang B, Huang B. Zhao J, et al. Among authors: cao y. Cancer Res. 2010 Jun 15;70(12):4850-8. doi: 10.1158/0008-5472.CAN-10-0283. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501849

5

Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.

Liu J, Zhao J, Hu L, Cao Y, Huang B. Liu J, et al. Among authors: cao y. Cell Mol Immunol. 2011 Jul;8(4):289-95. doi: 10.1038/cmi.2011.6. Epub 2011 Mar 21. Cell Mol Immunol. 2011. PMID: 21423201 Free PMC article. Review.

6

Low-dose oral cyclophosphamide therapy is effective for condylomata acuminata.

Zhang Y, Duan Y, Zhao J, Huang B, Cao YC. Zhang Y, et al. Among authors: cao yc. Chin Med J (Engl). 2013 Aug;126(16):3198-9. Chin Med J (Engl). 2013. PMID: 23981645 No abstract available.

7

Immunotherapy of HPV infection-caused genital warts using low dose cyclophosphamide.

Zhao J, Zeng W, Cao Y, Liang X, Huang B. Zhao J, et al. Among authors: cao y. Expert Rev Clin Immunol. 2014 Jun;10(6):791-9. doi: 10.1586/1744666X.2014.907743. Epub 2014 May 12. Expert Rev Clin Immunol. 2014. PMID: 24819873 Review.

8

Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages.

Cao Y, Liu C, Gu Z, Zhang Y, Duan Y, Zhang Y, Zhang H, Tang K, Huang B. Cao Y, et al. Cell Mol Immunol. 2017 Apr;14(4):395-397. doi: 10.1038/cmi.2015.30. Epub 2015 Apr 20. Cell Mol Immunol. 2017. PMID: 25891215 Free PMC article. No abstract available.

9

NAV2 facilitates invasion of cutaneous melanoma cells by targeting SNAI2 through the GSK-3β/β-catenin pathway.

Hu W, Li X, Cheng R, Ke J, Liu Y, Ma M, Cao Y, Liu D. Hu W, et al. Among authors: cao y. Arch Dermatol Res. 2019 Jul;311(5):399-410. doi: 10.1007/s00403-019-01909-w. Epub 2019 Apr 17. Arch Dermatol Res. 2019. PMID: 30997569

10

Enhanced Glycogen Metabolism Supports the Survival and Proliferation of HPV-Infected Keratinocytes in Condylomata Acuminata.

Gu Z, Zhang H, Guo X, Cao Y. Gu Z, et al. Among authors: cao y. J Invest Dermatol. 2020 Aug;140(8):1513-1523.e5. doi: 10.1016/j.jid.2020.01.010. Epub 2020 Jan 29. J Invest Dermatol. 2020. PMID: 32004566 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,716 results

Search Page

Filters